Home

Medical Research

Clinical studies, therapeutic evidence, regulatory review, and medical cannabis research developments.

Explore recent NewLeaf News reporting in medical research, including policy updates, market context, and source-linked coverage relevant to this beat.

Category feed

Follow this topic in your feed reader or use it as a stable landing page for discovering published coverage.

Subscribe to the Medical Research feed

Long COVID, Neuroinflammation, and the Interest in Cannabinoid Research

Medical ResearchExpanded

Scientific interest in cannabinoids and Long COVID originates from identifiable biological and clinical observations — but evidence for treatment remains limited

Millions of people continue to experience symptoms months or years after recovering from COVID-19. Researchers studying Long COVID continue to investigate inflammation, neuroinflammation, and immune dysfunction — the same systems examined in cannabinoid research. Here is what the science currently supports.

2026-06-05T20:37:29.035Z

40 views